clinical trial · NCT05419180
Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
Pharmacoresistant Focal EpilepsiesStiripentol
brief summary
This is a monocentric, open-label clinical study, presenting a retrospective part and a prospective part, studying the data of patients with drug-resistant focal epilepsies and treated with the combination of stiripentol (Diacomit®) and Carbamazepine.
started
Oct 13, 2022
primary completion
Jun 13, 2024
completion
Jun 13, 2024
last updated
Jul 24, 2024
official title
Study of the Interest of the Combination of Stiripentol (Diacomit®) and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol